Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Youssef M.K Farag"'
Autor:
Farjah H Algahtani, Youssef M.K Farag, Abdulrahman M Aljebreen, Nahla A Alazzam, Aamer S Aleem, Fouad F Jabri, Mohammad H Rajab, Mohamed M Shoukri
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 22, Iss 6, Pp 423-427 (2016)
Background/Aims: Inflammatory bowel disease (ulcerative colitis and Crohn's disease) is characterized by a chronic inflammatory condition, and is accompanied by abnormalities in coagulation and a hyper-coagulable state. This study was conducted to ex
Externí odkaz:
https://doaj.org/article/4b2fadb3a21f4bdbb65837ca497e2310
Autor:
Debbie S. Gipson, Maisha Pal, Hailey Desmond, Charles Anderson, Liron Walsh, Howard Trachtman, Susan F. Massengill, Patrick Gipson, Panduranga S. Rao, Joshua Thurman, Jeffrey Kopp, Elaine Kamil, Jennifer Lamothe, Laura H Mariani, Paula LaFleur, Suzanne Vento, Michelle O’Shaughnessy, Youssef M.K. Farag, Christine Simon, Noelle E. Carlozzi
Publikováno v:
Glomerular Diseases (2023)
Introduction: Edema is a common manifestation of proteinuric kidney diseases but there is no consensus approach for reliably evaluating edema. The objective of this study was to develop an edema clinician-reported outcome measure for use in patients
Externí odkaz:
https://doaj.org/article/087287d5e24644b286231e19975d9394
Autor:
Steven N. Michalopoulos, Marjolaine Gauthier-Loiselle, Myrlene Sanon Aigbogun, Elizabeth Serra, Rebecca Bungay, Diana Clynes, Martin Cloutier, Erin Kahle, Annie Guérin, Youssef M.K. Farag, Jay B. Wish
Publikováno v:
Kidney Medicine, Vol 4, Iss 4, Pp 100439- (2022)
Rationale & Objective: Chronic kidney disease (CKD) has a far-reaching impact on both patients and care partners, which can be further compounded by frequent complications such as anemia. This study assessed the burden experienced by patients with CK
Externí odkaz:
https://doaj.org/article/99410c57ffd84e34a73e880fd4d48149
Autor:
Dina M. Bassiouny, Youssef M.K. Farag, Mohamed F. Al Soda, Aliaa E. M. Daifalla, Amal Ahmed Mohamed, Nermeen Ibrahim Bedair, Naglaa Fawazy, Eman Mohamed Salah, Ola G. Behairy
Publikováno v:
Egyptian Pediatric Association Gazette, Vol 69, Iss 1, Pp 1-5 (2021)
Background Atopic dermatitis is characterized by impaired skin barrier and altered cutaneous innate immunity. The estimated prevalence among Egyptian children was 10–12%. Several studies suggest that it may be associated with systemic comorbidities
Objectives The results were inconsistent with the association between psoriasis and periodontitis. To better understand the strength and nature of the association between oral conditions and psoriasis by analysis of a large number of adults in the Un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a27fbe7fe5892b357c676bc3af189236
https://doi.org/10.21203/rs.3.rs-2182631/v1
https://doi.org/10.21203/rs.3.rs-2182631/v1
Autor:
Nancy Perrin, Jocelyn C. Anderson, Jacquelyn C. Campbell, Michelle Patch, Gabor D. Kelen, Youssef M.K. Farag
Publikováno v:
J Emerg Nurs
Introduction Nonfatal intimate partner strangulation poses significant acute and long-term morbidity risks and also heightens women’s risk for future femicide. The lifetime prevalence of nonfatal intimate partner strangulation has been estimated to
Autor:
Youssef M.K. Farag, Kimberly A. Walters, Gabriel Bako, Wolfgang C. Winkelmayer, Kai-Uwe Eckardt, Prabir Roy-Chaudhury, Dennis Vargo, Rajiv Agarwal, Amit Sharma, Mark J. Sarnak, Kunihiro Matsushita, Mark J. Koury, Bruce Spinowitz, Glenn M. Chertow, Wenli Luo, Patrick S. Parfrey, Zeeshan Khawaja, Susan Arnold, Eldrin F. Lewis, Steven K. Burke, Fausto P. Castillo, Alan G. Jardine, Carol Tseng, Bradley J. Maroni, Pablo E. Pergola, Peter A. McCullough, Janet Wittes, Tim Lin, Geoffrey A. Block, James A. Tumlin
Publikováno v:
New England Journal of Medicine. 384:1589-1600
Background Vadadustat is an oral hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, a class of drugs that stabilize HIF and stimulate erythropoietin and red-cell production. Meth...
Autor:
Dennis Vargo, Youssef M.K. Farag, Emil M. deGoma, Masaomi Nangaku, Wenli Luo, Zeeshan Khawaja
Publikováno v:
Nephrology Dialysis Transplantation. 36:1244-1252
Background Vadadustat is an investigational, oral hypoxia-inducible factor prolyl hydroxylase inhibitor in development in Japan for the treatment of chronic kidney disease (CKD)-induced anemia. Methods Two Phase 2, multicenter, double-blind, placebo-
Autor:
Prabir Roy-Chaudhury, Youssef M.K. Farag, Ajay K. Singh, Vanesa Bijol, Kenar D. Jhaveri, Adeera Levin, David Harris
Publikováno v:
Kidney International. 96:258-261